These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8521164)

  • 1. Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells.
    Hoffstedt J; Shimizu M; Sjöstedt S; Lönnqvist F
    Obes Res; 1995 Sep; 3(5):447-57. PubMed ID: 8521164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.
    Van Harmelen V; Lönnqvist F; Thörne A; Wennlund A; Large V; Reynisdottir S; Arner P
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):972-9. PubMed ID: 9368819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a functional beta 3-adrenoceptor in man.
    Lönnqvist F; Krief S; Strosberg AD; Nyberg S; Emorine LJ; Arner P
    Br J Pharmacol; 1993 Nov; 110(3):929-36. PubMed ID: 7905344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor.
    Galitzky J; Langin D; Verwaerde P; Montastruc JL; Lafontan M; Berlan M
    Br J Pharmacol; 1997 Nov; 122(6):1244-50. PubMed ID: 9401793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men.
    Hoffstedt J; Arner P; Hellers G; Lönnqvist F
    J Lipid Res; 1997 Apr; 38(4):795-804. PubMed ID: 9144094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
    Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M
    Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of an in vivo functional beta 3-adrenoceptor in man.
    Enocksson S; Shimizu M; Lönnqvist F; Nordenström J; Arner P
    J Clin Invest; 1995 May; 95(5):2239-45. PubMed ID: 7738189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist and antagonist properties of beta 3-adrenoceptors in human omental and mouse 3T3-L1 adipocytes.
    Shimizu M; Blaak EE; Lonnqvist F; Gafvels ME; Arner P
    Pharmacol Toxicol; 1996 Apr; 78(4):254-63. PubMed ID: 8861784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet.
    Hellström L; Reynisdottir S; Langin D; Rössner S; Arner P
    Int J Obes Relat Metab Disord; 1996 Aug; 20(8):745-52. PubMed ID: 8856398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.
    Lönnqvist F; Thöme A; Nilsell K; Hoffstedt J; Arner P
    J Clin Invest; 1995 Mar; 95(3):1109-16. PubMed ID: 7883959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells.
    Hellmér J; Marcus C; Sonnenfeld T; Arner P
    J Clin Endocrinol Metab; 1992 Jul; 75(1):15-20. PubMed ID: 1320047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism.
    Hellström L; Wahrenberg H; Reynisdottir S; Arner P
    J Clin Endocrinol Metab; 1997 Jan; 82(1):159-66. PubMed ID: 8989252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
    Germack R; Starzec AB; Vassy R; Perret GY
    Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
    Galitzky J; Reverte M; Carpene C; Lafontan M; Berlan M
    J Pharmacol Exp Ther; 1993 Jul; 266(1):358-66. PubMed ID: 8101220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives.
    Hellström L; Langin D; Reynisdottir S; Dauzats M; Arner P
    Diabetologia; 1996 Aug; 39(8):921-8. PubMed ID: 8858214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Adrenergic control of lipolysis in primate white fat cells: a comparative study with nonprimate mammals.
    Bousquet-Mélou A; Galitzky J; Carpéné C; Lafontan M; Berlan M
    Am J Physiol; 1994 Jul; 267(1 Pt 2):R115-23. PubMed ID: 7914069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
    Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes.
    Tavernier G; Barbe P; Galitzky J; Berlan M; Caput D; Lafontan M; Langin D
    J Lipid Res; 1996 Jan; 37(1):87-97. PubMed ID: 8820105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.
    Barbe P; Millet L; Galitzky J; Lafontan M; Berlan M
    Br J Pharmacol; 1996 Mar; 117(5):907-13. PubMed ID: 8851509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of growth hormone on the function of beta-adrenoceptor subtypes in rat adipocytes.
    Yang S; Mulder H; Holm C; Edén S
    Obes Res; 2004 Feb; 12(2):330-9. PubMed ID: 14981226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.